Study examines link between cholesterol lowering drugs and muscle cramps

Sep 10, 2008 by Suzanne Morrison

Cramps, muscle soreness, pain and weakness. Sounds like a bad day at the Olympics. No. They're the side-effects millions of people suffer when they take cholesterol-lowering drugs or statins, drugs designed to protect against a potential heart attack or stroke. Their discomfort isn't life-threatening -- just a nuisance -- but it makes many patients uncomfortable enough that they stop taking them.

Worldwide, about 52 million patients are prescribed statins. Up to 30 per cent of these patients suffer some sort of muscle pain, causing more than half of them to want off the drug.

That decision has significant implications, said Dr. Steven Baker, an assistant professor in the Department of Medicine at McMaster University's Michael G. DeGroote School of Medicine.

They could wind up in a coronary care unit or medical ward and need cardiac rehabilitation as well as blood pressure and blood thinning drugs -- all adding up to billions of dollars in costs to the health care system.

Baker believes the answer to preventing muscle problems caused by statins may be in adding a safe natural health product to the patient's treatment regime. To prove his hypothesis, he has a 40-patient study underway -- the first of its kind.

Volunteers are being sought who have been diagnosed with high cholesterol but haven't yet started on a cholesterol-lowering drug. During the eight-week study, all 40 patients are prescribed a cholesterol-lowering drug. In addition, half receive a natural health product while half get a placebo.

As well, creatine kinase (CK) -- a muscle enzyme -- will be measured and subjects will undergo a 45-minute treadmill test and blood and strength tests. Muscle biopsies at the beginning and end of the study will allow Baker to see how much of the supplement gets into and stays in the muscle.

The goal, Baker said, is to find out if the natural supplement can reduce muscle symptoms while patients are taking statins.

Provided by McMaster University

Explore further: Investigational drug improves sleep disorder among the blind

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

US: 'Pay to delay' generic drugs can be illegal (Update)

Jun 17, 2013

The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and ...

Medications to prevent clots not reaching some patients

Jun 14, 2013

Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say ...

User comments : 0

More news stories

Study evaluates procedures for diagnosing sarcoidosis

Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic ...

Respect may be the key to stopping patient 'no shows'

People with HIV are more likely to keep their scheduled medical appointments—and their disease under control—if they feel their physician listens, explains things clearly and knows them as a person, not just a "case," ...